chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial information received on 08-Aug-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 58 years old female patient who experienced red pin point rash over her torso, thighs and bilateral arms and observed a red pin point rash, which was very itchy, while she received vaccine ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On 02-Aug-2018, the patient received a 0.5 ml dose of suspect ADACEL lot U5656AA in the left deltoid (expiry date, dose in series and route not reported). On an unknown date, 4-5 hours following the vaccination the patient developed a non-serious red pin point rash over her torso, thighs and bilateral arms (injection site erythema) 4-5 hours following the administration of ADACEL. On an unknown date, the patient developed a non-serious observed a red pin point rash, which was very itchy (rash pruritic) following the administration of ADACEL. Other relevant tests included No lab data was reported. Final diagnosis was observed a red pin point rash, which was very itchy and red pin point rash over her torso, thighs and bilateral arms. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for observed a red pin point rash, which was very itchy and as Unknown for red pin point rash over her torso, thighs and bilateral arms. List of documents held by the sender: None.
Generalized body aches and chills.  Swollen lymph nodes in R axilla, R neck and both sides of groin.  Fatigue but unable to sleep.  Pain, redness, warmth  and swelling at injection site.  No fever.  Body aches especially bad in lower and upper back.
Rash with itching started on both inside of arms. Hydrocortisone  cream used until rash went away. Then rash moved to neck same treatment used but didn?t go away. Caladryl used to stop itch rash still visible. Rash with intense itching started under navel waist area hydrocortisone used first but still exist. Caladryl controlling the itching. Area under breast stopped with hydrocortisone but when it continued with intensivity caladryl used to stop itching. Started around June 13 until present date June 23, 2021 rash in areas still exist itching can be stopped or control with use of Caladryl .
Roughly twenty days after vaccination, I had a thalamic stroke, diagnosed by CT scan and MRI at Hospital. No underlying risk factors.  Stroke caused sensory  damage but no apparent mental or mobility effects. Having read the Reuters summary of the concerns about Pfizer bivalent I thought I should report this.
Patient required hospitalization due to breakthrough infection. He received Pfizer vaccine (2nd dose in series) on 03/19/21. Patient was hospitalized from 08/25/21 - 08/28/21. Below is copied from discharge summary:   Acute respiratory failure with hypoxia 2/2 COVID 19 PNA: - uptititrate O2 as needed to keep O2 sat>92 - continue Decadron IV - continue IV Remdesevir, monitor LFT's  - symptom management with prn meds - Isolation   Hyperlipidemia - lipitor 80 mg daily   Hypokalemia, resolved -Monitor   Elevated LFTs monitor   AKI/Urine retention, improved - Flomax 0.4 mg daily   Vit D deficiency: -Vit D 1.25 mg weekly   Elevated troponin, likely from demand ischemia -Telemetry   Left lung mass: - 1.5 cm - F/U OPD with CT chest as recommended by Radiology   HTN, fairly well controlled - Stable - Resume losartan, hold HCTZ - continue amlodipine   Insomnia: Continue trazodone   CAD s/p DES: - Stable ASA+statin   Morbid Obesity, BMI of>40: - would benefit from lifestyle modifications regarding low fat diet, weight loss and daily excercise - F/U OPD with PCP   Vitals and labs personally reviewed.   PT/OT:  DVT PPx. Lovenox   His electrolytes, pain and vitals were monitored and optimized during the course of hospitalization. Patient's symptoms improved and he remained hemodynamically stable.   Patient wanted to go home and self isolate at home.    6 MIN WALK TEST WAS DONE, PT SENT HOME ON HOME O2   POOR ADHERENCE AND POOR INSIGHT, HIGH RISK OF RE-ADMISISON   Discharge Diagnoses: Acute respiratory failure with hypoxia 2/2 COVID 19 PNA
Very anxious prior to injection, became lightheaded directly after injection.  Then became nauseated and began vomiting.  Diaphoretic and pale in color, assisted to monitoring room with cot for client to lay down.  Became chilled ,warm blankets placed on client and continued to monitor.   PSO2 99 %        b/p120/78     pulse 80      Client improved ready to be released.  Informed to see medical attention for any further problems.
22DEC95 fever x 12k; 28DEC95 sz 9PM-fever encephalopathy
exposed to his son that tested positive; chills; green Phlegm; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient, self-reported). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration dates were unknown) on 21Jan2021 and second dose on 11Feb2021: both via an unspecified route of administration, as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient stated that she was exposed to his son that tested positive. Now she was experiencing chills and green Phlegm. At the time of reporting the outcome of the events were unknown.  No follow up attempts are possible; information about lot/batch number cannot be obtained.
3 days p/vax pt felt like had flu w/an upset stomach;pt also devel a 26mm x 63mm area of induration @ the inj site;pt recovered;this is 1 of 12 patients from this site to have an adverse rxn;
Severe body aches; headache; nausea; diarrhea; exhaustion; This is a spontaneous report from a contactable nurse. A 49-years-old female patient (no pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , intramuscular on 06Jan2021 16:30 at the first single dose for covid-19 immunisation.  Medical history included ongoing hypertension , ongoing hypothyroidism , ongoing blood cholesterol increased , Known allergies: Sulfa.  The patient's concomitant medications were not reported.  The patient experienced severe body aches, headache, nausea, diarrhea, exhaustion on 07Jan2021 03:00.  The patient did not receive any treatment for the events. The outcome of events was not recovered.  Information on the lot/batch number has been requested.
There was not adverse reaction to vaccine. While administering vaccine, some of the vaccines leaked out the syringe. We are unsure of the amount of vaccine that leaked out.
Chest pain and feeling like I had to constantly take deep breaths that both began within 5 minutes of receiving the first COVID vaccine by moderna. Symptoms lasted approximately 24 hours and then resolved.
approx 15 min p/ pt recv vax pt devel a large area of erythema & a 1cm wheal at inject site. treated w/benadryl
This spontaneous report as received from a unknown reporter via company representative refers to a 13 year old male patient. The patient's medical history and current conditions were not reported. On 16-OCT-2017, the patient was vaccinated with first dose of GARDASIL or GARDASIL 9 (dose, route and indication were not reported). In approximately October 2017, the patient became lightheaded and sweaty. The outcome of the events was reported as recovered with no issues, after sitting for a short time. Additional information is not expected. No correspondence contact was provided therefore no correspondence letter can be sent.
Hard bump got larger in 24 hours the injection site was red and swollen. Patient complained of pain.
flu like symptoms; cough; no sense of taste; no sense of smell; arm pain; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm pain), INFLUENZA LIKE ILLNESS (flu like symptoms), COUGH (cough), AGEUSIA (no sense of taste) and ANOSMIA (no sense of smell) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN, ROSUVASTATIN, METFORMIN, LEVOTHYROXINE, PROBIOTICS NOS, TOCOPHERYL ACETATE (VITAMIN E [TOCOPHERYL ACETATE]), XANTOFYL, ZEAXANTHIN (LUTEIN ZEAXANTHIN), VITAMIN D3 and UBIDECARENONE (COQ10 [UBIDECARENONE]) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 09-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), COUGH (cough), AGEUSIA (no sense of taste) and ANOSMIA (no sense of smell). The patient was treated with ACETAMINOPHEN ongoing since an unknown date at an unspecified dose and frequency. On 06-Feb-2021, PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), COUGH (cough), AGEUSIA (no sense of taste) and ANOSMIA (no sense of smell) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Narrative:  COVID infection after completion of COVID vaccine series 04/21 COVID vaccine dose #1 05/19 COVID vaccine dose #2 06/21 COVID tested due to pre-procedure testing, COVID positive, asymptomatic
Headache started after 2nd dose?started Wednesday evening. Diarrhea on Thursday. Headache continued. Night sweats on Thursday to the point of waking up soaked. Friday headache continued, no energy.  Saturday felling slightly better and by Sunday appetite returned. Treated with IBP and Tylenol plus rest.
Mom called office on 7/18/07 notices child is hoarse. No other symptom, instructed to monitor. Seen in office 7/19/07 with c/o hoarseness only. Question 2nd viral croup, extra crying vocal cord abuse. Report VAERS - possible side effect.
I have a pre existing auto immune disease.  Alopecia.  I have only had 2 outbreaks, one at 18 yrs age and one at 40yrs age.  Within 3 days of the shot a collegue notice a bald spot on my head.  After further inspection I found 9 sites of baldness due to the Moderna shot.  I went to a dermatologist and she confirmed that it looked like an auto immune respone to the vaccine.  So far this has cost $600.00.  After 1 month of using dr. prescribed medicine the hair has not grown back yet.
GAVE A PATIENT A HBV#1 IN LEFT DELTOID, THEN GAVE HPV#1 IN RIGHT VASTUS LATERALIS, PT GOT WHITE, AND PASSED OUT.  PT DID NOT FALL, NOR HIT HIS HEAD.  PT WAS OUT FOR ABOUT 10 SECONDS.
Date the vial was initially stored in the refrigerator was 12May2022 and Exp: 02May2022; We administered 9 doses of expired Moderna Covid-19 vaccine on 13May2022.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We administered 9 doses of expired Moderna Covid-19 vaccine on 13May2022.) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12May2022 and Exp: 02May2022) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 045J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 13-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (We administered 9 doses of expired Moderna Covid-19 vaccine on 13May2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12May2022 and Exp: 02May2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We administered 9 doses of expired Moderna Covid-19 vaccine on 13May2022.) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12May2022 and Exp: 02May2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided. The vial did not undergone any temperature excursions.
, I had slight fever 99.6-101.0 and chills for a period of 8 hours
scabies; itching; rash neck to waist down/she developed a rash on her back; This is a spontaneous report from a contactable consumer (patient). A 93-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number unknown), via an unspecified route of administration on 29Dec2020 at a single dose for COVID-19 immunization. Medical history included pacemaker. The patient's concomitant medications were not reported. She received the COVID vaccine on 29Dec2020 and 10 days later she developed a rash neck to waist down, she is in the nursing home and they are not sure if its scabies, she said the itching has lessened. She is in the nursing home for follow up for her pacemaker. caller wanted to know if there are reports of rash. Patient wanted to know about partial immunity (immunity after the first dose) and how long it takes to build it. Reporter wanted to find out if anyone reported a skin rash after having the Covid shot. Stated that her rash started 10 days later on her back and it looked like scabies. Stated that it will be treated as scabies. Stated the she did a report about the above mentioned previously. Stated that she is going to see her doctor later on today. It was also reported that she had the COVID vaccine 29Dec2020 and 10 days later on 07Jan2021, she developed a rash on her back and she was wondering if this was normal. It was confirmed that the patient was given the Pfizer BioNtech COVID-19 vaccine on 29Dec2020 and then developed a rash on her back 07Jan2021. She was asking if this was from the shot? Is the rash something that has been reported before? How long until she has some sort of immunity after getting first vaccine? She was not sure it is a side effect for sure. The aid at the nursing home thought it was scabies. But the patient has not been in contact with anyone with scabies, and has a clean bed and everything. The outcome of the event 'itching' was recovering while unknown for the other events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient received a dose of meningococcal B vaccine (Trumenba, lot # FJ4128) which was not medically indicated for the patient.
Immediate pain at injection site. Decreased mobility and pain in shoulder gradually worsened. Physical therapy, anti-inflammatories, and 2 cortisone shot given. Pain increased and mobility decreased. Arthroscopic shoulder surgery performed 2/22/10. Same course of treatment after surgery. Still in pain, decreased mobility, modified job duties.
Fever and seizure developed on 05/20/05, was hospitalized 5/20-24/05 Discharged- Dx- fever, anemia, increased mononucleocytes, febrile seizures, otitis media, staphcapitis, coag neg. sepsis.
This is in follow-up to report (s) previously submitted on 05/16/2008. Information has been received from a pediatrician's office concerning a 8 year old white female consumer with no known allergies and no pertinent medical history who on 24-AUG-2001 was vaccinated at another office with varicella virus vaccine live (Oka/Merck). Concomitant vaccinations included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown) and hepatitis B vaccine, recomb (manufacturer unknown). Subsequently, on 21-FEB-2008 the patient developed crops of erythemous lesions on her body behind her ears, arms, face and eye lids, about 3-4 dozen spots, no pustules. Medical attention was sought, the patient was seen in the pediatrician's office at 3:30 pm, there were no lab studies performed. The patient was diagnosed with atypical chicken pox. At the time of the report the patient had not recovered, she currently had an outbreak.  It was reported that the patient was doing very well. Additional information has been requested. Addition information is not expected.
Information has been received from a nurse concerning a 25 year old female who received 0.5 ml of the first dose of Gardasil on an unspecified date. Concomitant therapy included DEPO-PROVERA. It was reported that the patient experienced dehydration and flu-like symptoms one week after receiving the vaccination. She went to the emergency room (ER). On an unspecified date, the patient was vaccinated with a second dose of Gardasil. Two weeks after receiving her second dose of Gardasil, she ad the same symptoms, but they were not as severe. The patient's outcome was unknown. Additional information has been requested.
Tested positive for Covid after both vaccines; Tested positive for Covid after both vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 41 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Mar2021 (Lot number: EL3247) as dose 2, single and administered in arm left, administration date 24Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 26Nov2021, outcome "unknown" and all described as "Tested positive for Covid after both vaccines". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (26Nov2021) positive.  Additional information: There was no predisposing factors reported for the patient. The patient did not receive any specific antipyretics around the dates of vaccination.  No follow-up attempts are needed. No further information was expected.
At the time of injection I felt a pressure pain radiating diagonally downward toward my armpit.  Where she injected me was very high up on my arm almost close to the top.  The pain at injection site was quite sore for the first few days and then went away for the most part for a day or two but has now come back much worse.  It hurts to lift my arm or move it and feels like I've lost strength to raise my arm.   I am in constant pain now and my arm around the injection site is painful when I press down especially on the bony area.
Woke night up terrible pain in left hand, palm and fingers. Next couple days, left arm ached like flu, went across shoulder and down right arm to hand-HA's not been normal to this date 3/30/04. Left fingers are numb and hurt like have been too cold. Right fingers not as bad as left-after 4 mo some better. Went to Dr 12/8/03. Ibuprofen for pain. Still not normal. Constant pain and numbness sometime better/ worse-has never gone away. Where shot given-still sore. Information from Annual Follow-up report states not completely - still numbness in fingers all time. But not as bad and not near the pain.
Broke out in full body rash. Severely itchy to where I couldn't sleep at night and was tearing my skin open itching. Totally unbearable. Had to telehealth a doctor on saturday, 3 days later because I hadn't slept and could not stoSaturday, and my skin was opening due to this. Was told by the MD that it was a reaction to the covid vaccine and that I would need a prednisone burst of 40mg for 5 days. I completed that and I still have "growths" under my skin that have not gone away and continue to itch. The itch has never gone away and I'm still tearing my skin open because of this on a daily basis.
fever of 102.4; chills; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 73-years-old) at 11:30 as a single dose for COVID-19 immunisation. The patient did not have any medical history. The did not have a history of allergy to medications, food, or other products. Concomitant medications included losartan (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN); all for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 02Mar2021 at 02:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. The patient underwent lab tests and procedures which included COVID-19 virus test via nasal swab on 15Mar2021 and the result found to be negative. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 03:00, the patient had experienced fever of 102.4 (unspecified units) and chills. The clinical outcome of the events fever of 102.4 and chills was resolved on unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Pt got vaccine (2nd dose). First Shingrix Jan 29 pt got sore arm couple days & fine. This vaccine received the workout hard at pounding truck tires. (R) shoulder sore yet 5/17/19.
Pain in hands, middle finger joint issue, forearms hurting, both shoulders and neck pain, ankle pain and shin pain? seemed like most major joints? most of these bilateral. No treatment yet. Diagnosed with polyarthralgia.
On 10/5/2021 I had a very sore throat. On 10/7/2021 I started sneezing a lot but the sore throat went away. On 10/8/2021 I was coughing with mucus. On 10/9/2021 I had severe coughing. congestion, sinus pressure but no fever. I went to urgent care on 10/9/2021 and they put on amoxicillin potassium and I am on my last day of meds as of today 10/18/2021. They also gave me Flonase which I have been using every day.
pt recvd vax 15APR94 & 8JUN had whoops & paroxyms; rx'd w/Pediazol & Ventolin x 3 wks; infant improving; dx pertussis on 22JUN94; FA pos for B pertussis; no nasopharyngeal cultures taken; no known contacts; 11JUL94 recvd 4mo vax;
Received the vaccine on 4/10/2021 with no severe signs/symptoms. Woke up next morning (4/11/2021) with rash over about 10% of my body. By that night, the rash spread to 60% of my body. On  4/12/2021 the rash spread to nearly all remaining areas of my body so the rash has been to nearly 100% of my skin at least once since I received the vaccine.
Headache, Myalgia, Fever, Joint Pain, Fatigue.  Narrative:  Other Relevant History: